|
|
|
|
|
1
|
Algae For Fuel, Algal Oil, Biofuels, Biodiesel, Ethanol And The Future Of Petroleum And Green Energy |
Nov 2009 |
$2,900.00 |
|
This research provides an overview on what could become one of the most significant technological and economic events of the early 21st century: turning algae into fuel, i.e. algal oil, on a commercial scale. If
more...
Published by: Amadee & Company
| Search inside this report |
|
|
2
|
Biotechnology (Pharmaceuticals) Report |
Nov 2009 |
$1,500.00 |
|
The Global Biotechnology Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation
more...
Published by: Plimsoll Publishing Ltd.
|
|
|
3
|
Opportunities in Human Embryonic Stem Cell (hESC) Products |
Nov 2009 |
$3,495.00 |
|
Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post fertilization. They are the most pluripotent of all stem cell
more...
Published by: BioInformant Worldwide, L.L.C.
| Search inside this report |
|
|
4
|
Global Stem Cell and Advanced Technologies Market |
Nov 2009 |
$4,650.00 |
|
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and
more...
Published by: MarketsandMarkets
| Search inside this report |
|
|
5
|
Protein Kinase Therapeutics in Oncology - Where to Commercialize? |
Oct 2009 |
$3,500.00 |
|
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of
more...
Published by: BioSeeker Group AB
|
|
|
6
|
Acorda Therapeutics, Inc. - SWOT Analysis |
Oct 2009 |
$125.00 |
|
Datamonitor's Acorda Therapeutics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Acorda Therapeutics, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and
more...
Published by: Datamonitor
| Search inside this report |
|
|
7
|
Future of Green Biotechnology in China |
Oct 2009 |
$6,650.00 |
|
This report is the unique and latest one available in the world to provide good understanding about Green Biotechnology (GB) in China and to find out business opportunities in this field. The first edition of
more...
Published by: CCM International Limited
|
|
|
8
|
Scientific Research in Australia - Industry Risk Rating Report |
Oct 2009 |
$810.00 |
|
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Scientific Research in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
more...
Published by: IBISWorld
| Search inside this report |
|
|
9
|
Biotechnology in Australia - Industry Risk Rating Report |
Oct 2009 |
$810.00 |
|
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating
more...
Published by: IBISWorld
| Search inside this report |
|
|
10
|
Biotechnology in the US - Industry Risk Rating Report |
Oct 2009 |
$825.00 |
|
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
more...
Published by: IBISWorld
| Search inside this report |
|
|
11
|
Crucell N.V. - SWOT Analysis |
Oct 2009 |
$125.00 |
|
Datamonitor's Crucell N.V. - SWOT Analysis company profile is the essential source for top-level company data and information. Crucell N.V. - SWOT Analysis examines the company’s key business structure and operations, history and products, and
more...
Published by: Datamonitor
| Search inside this report |
|
|
12
|
Elan Corporation, plc - SWOT Analysis |
Oct 2009 |
$125.00 |
|
Datamonitor's Elan Corporation, plc - SWOT Analysis company profile is the essential source for top-level company data and information. Elan Corporation, plc - SWOT Analysis examines the company’s key business structure and operations, history and
more...
Published by: Datamonitor
| Search inside this report |
|
|
13
|
Biotechnology: Global Industry Guide |
Oct 2009 |
$1,495.00 |
|
Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive
more...
Published by: Datamonitor
| Search inside this report |
|
|
14
|
Lonza Group Ltd - SWOT Analysis |
Oct 2009 |
$125.00 |
|
Datamonitor's Lonza Group Ltd - SWOT Analysis company profile is the essential source for top-level company data and information. Lonza Group Ltd - SWOT Analysis examines the company’s key business structure and operations, history and
more...
Published by: Datamonitor
| Search inside this report |
|
|
15
|
XOMA Ltd. |
Oct 2009 |
$32.00 |
|
XOMA is a leading biopharmaceutical company in the field of therapeutic antibody discovery and development. We have a royalty interest in one approved therapeutic antibody, RAPTIVA (efalizumab), which is marketed in the United States, Europe
more...
Published by: SGA Lists
|
|
|
16
|
Transfection Life Science Dashboard™ Series 2 |
Oct 2009 |
$3,850.00 |
|
The ability to transfect DNA into mammalian cells and cell lines is a critical step in the analysis of gene expression, protein structure and function and molecular interactions within the cell. The Transfection Dashboard
more...
Published by: Percepta Associates, Inc.
| Search inside this report |
|
|
17
|
Genentech Incorporated |
Oct 2009 |
$200.00 |
|
Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for significant unmet medical needs. A considerable number of the currently approved biotechnology products originated from,
more...
Published by: SGA Lists
|
|
|
18
|
Novo Nordisk Incorporated |
Oct 2009 |
$145.00 |
|
Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo
more...
Published by: SGA Lists
|
|
|
19
|
Regenerative Medicines: Bone and Joint Applications |
Oct 2009 |
$4,850.00 |
|
REPORT HIGHLIGHTS
Overall sales in the regenerative medicine productsmarket were worth $1.1 billion in 2007, and remained flat into 2009. By 2014, sales are projected to increase to nearly $1.8 billion, for a
more...
Published by: BCC Research
| Search inside this report |
|
|
20
|
MedImmune Inc. |
Oct 2009 |
$127.00 |
|
MedImmune is a leading innovation-focused biotechnology company whose mission is to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people
more...
Published by: SGA Lists
|
|
|
21
|
Millipore Corporation |
Oct 2009 |
$32.00 |
|
Millipore is a leading provider of products and services that improve productivity in biopharmaceutical manufacturing and in clinical, analytical and research laboratories. The Company is organized in two operating divisions. Its Bioprocess Division enables pharmaceutical
more...
Published by: SGA Lists
|
|
|
22
|
Imclone Systems Inc. |
Oct 2009 |
$44.00 |
|
ImClone Systems Incorporated is a biopharmaceutical company dedicated to developing breakthrough biologic medicines in the area of oncology. The Company has utilized the many advances made in the fields of molecular biology, oncology, genomics and
more...
Published by: SGA Lists
|
|
|
23
|
Covance Inc. |
Oct 2009 |
$59.00 |
|
Covance develops and carries out preclinical and clinical trials of potential commercial drugs. Services include toxicology studies, biostatistical analysis, clinical data management, and study design and monitoring. Covance will also assist a company in moving
more...
Published by: SGA Lists
|
|
|
24
|
EMD Serono, Inc |
Oct 2009 |
$52.00 |
|
Serono is a global biotechnology leader with over 4,750 employees and worldwide revenues of USD 2,586.4 million in the year 2005. We have eight biotechnology products on the market and currently more than 25 ongoing
more...
Published by: SGA Lists
|
|
|
25
|
Managed Markets Account Management: Assessing the Performance of Account Executives |
Oct 2009 |
$4,210.00 |
|
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth study to: identify common performance measurement practices across geographies and
more...
Published by: Best Practices, LLC
|
|
|
|
|
|
0 items
